History

Capsulution was founded in the year 2000 as a spin-off of the Max Planck Institute of Colloids and Interfaces in Golm. With the objective of developing high-value products for the life-science industry on the basis of its unique LBL technology® for the production of “intelligent” nanocapsules, and the award of the German Innovation Prize in 2000, our company was greeted with great interest from potential customers, investors and the public from the outset.

The founders and partners of our company include the Max Planck Society for the Advancement of Science as well as a number of inventors behind LBL technology®. Upon its founding Capsulution was granted the exclusive rights for the further development and global marketing of LBL technology®.

Right after its launch Capsulution obtained its first financing of around 3 million Euros from such sources as the venture capital firms Berlin Seed Capital Fund (BCF GmbH today) and the German Private Equity and Venture Capital Association (represented today by BC Brandenburg Capital GmbH) and tbg Technologie-Beteiligungs-Gesellschaft mbH.

Capsulution’s future-oriented development projects are also supported by public funding from such sources as Germany’s Federal Ministry of Education and Research.
Our customers and partners include a number of prominent industrial concerns. We have been able to achieve high rates of growth in recent years by building on business relationships that are generally cultivated over the long term.

In 2005 Capsulution was awarded the “Product Differentiation Innovation Award” by the renowned marketing research agency Frost & Sullivan.

Since then our company has continued to develop according to plan, and we have been able to close important contracts with customers and investors while significantly expanding Capsulution’s product pipeline.